Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA).
暂无分享,去创建一个
A. Folsom | D. Jacobs | J. Lima | D. Duprez | A. Maisel | C. Peralta | L. Daniels | O. Sanchez | H. Bahrami
[1] D. Jacobs,et al. Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis , 2015, Journal of hypertension.
[2] A. Folsom,et al. The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: the Multi-Ethnic Study of Atherosclerosis. , 2014, Metabolism: clinical and experimental.
[3] A. Khera,et al. Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. , 2013, Journal of the American College of Cardiology.
[4] J. Coresh,et al. NH2-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes , 2013, Diabetes.
[5] N. Cook,et al. Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women. , 2013, Clinical chemistry.
[6] L. Lind,et al. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years. , 2013, The American journal of cardiology.
[7] Thomas J. Wang,et al. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmo Diet and Cancer study. , 2012, The Journal of clinical endocrinology and metabolism.
[8] C. Passino,et al. Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations. , 2012, Advances in clinical chemistry.
[9] D. Jacobs,et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). , 2012, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] G. Pacini,et al. B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men , 2012, Diabetologia.
[11] B. Kestenbaum,et al. Kidney Function Decline in the Elderly: Impact of Lipoprotein-Associated Phospholipase A2 , 2011, American Journal of Nephrology.
[12] D. Levy,et al. Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals. , 2011, The American journal of cardiology.
[13] Inês Barroso,et al. Mendelian Randomization Study of B-Type Natriuretic Peptide and Type 2 Diabetes: Evidence of Causal Association from Population Studies , 2011, PLoS medicine.
[14] Chia-Jung Lu,et al. Development of a Novel , 2011 .
[15] H. Bøtker,et al. Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. , 2010, International journal of cardiology.
[16] D. Jacobs,et al. The association between physical activity and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis. , 2008, American journal of epidemiology.
[17] W. März,et al. N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study. , 2007, Clinical chemistry.
[18] D. Phelan,et al. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. , 2007, Journal of cardiac failure.
[19] W. März,et al. N-Terminal ProB-Type Natriuretic Peptide Predicts Total and Cardiovascular Mortality in Individuals with or without Stable Coronary Artery Disease : The Ludwigshafen Risk and Cardiovascular Health Study , 2007 .
[20] Alan H B Wu,et al. Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results. , 2006, American heart journal.
[21] A. Folsom,et al. Smoking, diabetes, and blood cholesterol differ in their associations with subclinical atherosclerosis: the Multiethnic Study of Atherosclerosis (MESA). , 2006, Atherosclerosis.
[22] S. Lai,et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. , 2006, AJR. American journal of roentgenology.
[23] G. Fonarow,et al. B-type natriuretic peptide levels in obese patients with advanced heart failure. , 2006, Journal of the American College of Cardiology.
[24] R. Turner,et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.
[25] R. Sarzani,et al. Role of the natriuretic peptide system in lipogenesis/lipolysis. , 2003, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[26] T. Mueller,et al. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. , 2003, Clinical chemistry.
[27] R. Kronmal,et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. , 2002, American journal of epidemiology.
[28] J. Karl,et al. Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.
[29] D. Garbers,et al. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. , 1992, The Journal of biological chemistry.
[30] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[31] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.